From: Self-administered succus entericus reinfusion before ileostomy closure improves short-term outcomes
 | SER group (n = 30) | Non-SER group (n = 42) | p value |
---|---|---|---|
Age, year, median (range) | 64(46–77) | 65(41–78) | 0.661 |
Gender (male/female) | 14/16 | 18/24 | 0.812 |
ASA classification | Â | Â | 0.447 |
 I | 8 | 16 |  |
 II | 22 | 26 |  |
Body mass index at index surgery (kg/m2) | 25.46 ± 1.98 | 26.49 ± 2.95 | 0.101 |
Body mass index at stoma closure (kg/m2) | 24.40 ± 1.96 | 25.23 ± 2.62 | 0.151 |
Distance from tumor to anal edge(cm) | 9.10 ± 3.48 | 8.14 ± 2.09 | 0.151 |
Neoadjuvant therapy | 6/24 | 10/32 | 0.780 |
Surgical approach of index surgery: laparoscopic/open | 28/2 | 38/4 | 1.000 |
Inter-surgery period (days) | 210.2 (98.0–413.0) | 150.7 (43.0–347.0) | 0.046 |
Albumin prior to stoma closure (g/l) | 42.34 ± 4.15 | 42.61 ± 5.98 | 0.830 |
WBC (109/l) | 5.51 ± 1.49 | 4.9161 ± 1.42 | 0.089 |
RBC (1012/l) | 4.17 ± 0.27 | 4.27 ± 0.30 | 0.160 |
Lymphocyte (109/l) | 1.43 ± 0.54 | 1.26 ± 0.62 | 0.228 |
Adjuvant therapy | 16/14 | 20/22 | 0.811 |